000 01445 a2200397 4500
005 20250515112340.0
264 0 _c20080515
008 200805s 0 0 eng d
022 _a0340-6245
024 7 _a10.1160/TH07-12-0718
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClemetson, Kenneth J
245 0 0 _aPlatelet GPIb complex as a target for anti-thrombotic drug development.
_h[electronic resource]
260 _bThrombosis and haemostasis
_cMar 2008
300 _a473-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAurintricarboxylic Acid
_xpharmacology
650 0 4 _aBlood Platelets
_xdrug effects
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Design
650 0 4 _aFibrinolytic Agents
_xpharmacology
650 0 4 _aHemostasis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMembrane Proteins
_xpharmacology
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aPeptides
_xpharmacology
650 0 4 _aPlatelet Glycoprotein GPIb-IX Complex
_xantagonists & inhibitors
650 0 4 _aStructure-Activity Relationship
650 0 4 _aThrombosis
_xblood
650 0 4 _avon Willebrand Factor
_xmetabolism
700 1 _aClemetson, Jeannine M
773 0 _tThrombosis and haemostasis
_gvol. 99
_gno. 3
_gp. 473-9
856 4 0 _uhttps://doi.org/10.1160/TH07-12-0718
_zAvailable from publisher's website
999 _c17829616
_d17829616